Fluphenazine decanoate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for fluphenazine decanoate and what is the scope of patent protection?
Fluphenazine decanoate
is the generic ingredient in two branded drugs marketed by Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, MSN, Mylan Labs Ltd, Teva Parenteral, and Bristol Myers Squibb, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.There are eight drug master file entries for fluphenazine decanoate. Eight suppliers are listed for this compound.
Summary for fluphenazine decanoate
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 10 |
NDAs: | 10 |
Drug Master File Entries: | 8 |
Finished Product Suppliers / Packagers: | 8 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 2 |
Patent Applications: | 3,080 |
Drug Prices: | Drug price trends for fluphenazine decanoate |
What excipients (inactive ingredients) are in fluphenazine decanoate? | fluphenazine decanoate excipients list |
DailyMed Link: | fluphenazine decanoate at DailyMed |
Recent Clinical Trials for fluphenazine decanoate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Immune Control | Phase 2 |
Tufts Medical Center | Phase 2 |
National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for fluphenazine decanoate
Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for fluphenazine decanoate
US Patents and Regulatory Information for fluphenazine decanoate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gland Pharma Ltd | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 215509-001 | Mar 30, 2023 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Parenteral | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 074795-001 | Sep 10, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 074966-001 | Apr 16, 1998 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Eugia Pharma | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 207739-001 | Oct 17, 2017 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bristol Myers Squibb | PROLIXIN DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 016727-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fresenius Kabi Usa | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 071413-001 | Jul 14, 1987 | AO | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.